Skip to main content
. 2021 Feb 10;5(2):e20.00154. doi: 10.5435/JAAOSGlobal-D-20-00154

Table 2.

Distribution of all Clinical Articles (n = 985) by Study Type and Level of Evidence, by Year of Publication

Study Type Clinical Articles (n = 985)a
1994 1999 2004 2009 2014 2019 P Value
Clinical
 Therapeutic 61 (54.0) 71 (62.3) 99 (60.0) 151 (74.8) 135 (65.9) 127 (68.3) <0.01b
 Prognostic 44 (38.9) 34 (29.8) 53 (32.1) 35 (17.3) 43 (21.0) 43 (21.0) <0.01b
 Diagnostic 8 (7.1) 7 (6.1) 12 (7.3) 16 (7.9) 23 (11.2) 14 (7.5) 0.59b
 Economic 0 (0.0) 2 (1.8) 1 (0.6) 0 (0.0) 4 (1.9) 2 (1.1) 0.23c
LOE
 I 4 (3.5) 2 (1.8) 10 (6.1) 7 (3.5) 13 (6.3) 12 (6.5) 0.29c
 II 6 (5.3) 5 (4.4) 13 (7.9) 12 (5.9) 27 (13.2) 29 (15.6) <0.01b
 III 18 (15.9) 14 (12.3) 38 (23.0) 41 (20.3) 60 (29.3) 66 (35.5) <0.01b
 IV 47 (41.6) 55 (48.2) 62 (37.6) 86 (42.6) 71 (34.6) 70 (37.6) 0.21b
 V 38 (33.6) 38 (33.3) 42 (25.4) 56 (27.7) 34 (16.6) 9 (4.8) <0.01b

LOE = level of evidence. All bolded p-values = 0.01.

a

Values displayed as n (%).

b

Chi squared analysis.

c

Fisher exact test.